Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Operating Leases (2023 - 2025)

Mangoceuticals (MGRX) has disclosed Operating Leases for 3 consecutive years, with $307822.0 as the latest value for Q4 2025.

  • Quarterly Operating Leases rose 373.85% to $307822.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $307822.0 through Dec 2025, up 373.85% year-over-year, with the annual reading at $307822.0 for FY2025, 373.85% up from the prior year.
  • Operating Leases hit $307822.0 in Q4 2025 for Mangoceuticals, up from $12167.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $307822.0 in Q4 2025 to a low of $12167.0 in Q3 2024.
  • Historically, Operating Leases has averaged $86457.1 across 3 years, with a median of $64961.5 in 2023.
  • Biggest five-year swings in Operating Leases: tumbled 85.07% in 2024 and later skyrocketed 373.85% in 2025.
  • Year by year, Operating Leases stood at $64961.0 in 2023, then increased by 0.0% to $64962.0 in 2024, then surged by 373.85% to $307822.0 in 2025.
  • Business Quant data shows Operating Leases for MGRX at $307822.0 in Q4 2025, $12167.0 in Q3 2025, and $30117.0 in Q2 2025.